Biotech organization to lead new antimicrobial resistance coalition

The Biotechnology Innovation Organization (BIO) this week announced the launch of a new coalition to raise public awareness of antimicrobial resistance (AMR) and advocate for policies to stimulate new antibiotic development.

The “Working to Fight AMR” coalition will be led by BIO, a trade organization that represents biotechnology companies and related organizations, and will include scientists, public policy experts, and industry leaders. The group says that, in addition to educating the public, it will advocate for policies like the DISARM Act, which calls for higher Medicare reimbursement for new antibiotics that treat serious or life-threatening infections…

CIDRAP

Biotech organization to lead new antimicrobial resistance coalition

August 21, 2019

More

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Fierce Biotech

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Sign up for the latest on fighting AMR